Finance

Lists
524164:BOM
IOL Chemicals and Pharmaceuticals Ltd
₹194,70
-0,21%
(-0,40) 1D
16 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524164...
Open
₹195,10
High
₹198,15
Low
₹191,20
Mkt. cap
57,09 mjd
Avg. vol.
276,60 k
Volume
110,25 k
Dividend
0,62%
Quarterly dividend
₹0,30
Ex-dividend date
17 Feb. 2026
P/E ratio
34,05
52-wk high
₹224,00
52-wk low
₹67,14
EPS
₹5,72
Shares outstanding
56,21 m
No. of employees
3 k
Open
₹195,10
High
₹198,15
Low
₹191,20
Mkt. cap
57,09 mjd
Avg. vol.
276,60 k
Volume
110,25 k
Dividend
0,62%
Quarterly dividend
₹0,30
Ex-dividend date
17 Feb. 2026
P/E ratio
34,05
52-wk high
₹224,00
52-wk low
₹67,14
EPS
₹5,72
Shares outstanding
56,21 m
No. of employees
3 k
News stories
From web sources and news partners
About IOL Chemicals and Pharmaceuticals Ltd
CEOSanjay Chaturvedi
Employees3,1 k
Founded1986
Headquarters-
SectorPharmaceutical industry
Websiteiolcp.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
5,68 mjd
5,80 mjd
6,19 mjd
7,56 mjd
Cost of goods sold
3,68 mjd
3,82 mjd
4,02 mjd
4,78 mjd
Cost of revenue
3,68 mjd
3,82 mjd
4,02 mjd
4,78 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
633,50 m
569,30 m
719,60 m
712,10 m
Operating expense
1,62 mjd
1,61 mjd
1,45 mjd
1,96 mjd
Total operating expenses
5,30 mjd
5,43 mjd
5,46 mjd
6,74 mjd
Operating income
370,90 m
371,00 m
729,50 m
821,50 m
Other non operating income
68,80 m
52,90 m
-209,50 m
81,80 m
EBT including unusual items
404,90 m
275,50 m
708,10 m
866,90 m
EBT excluding unusual items
404,90 m
387,60 m
714,60 m
866,90 m
Income tax expense
105,20 m
69,70 m
176,50 m
222,90 m
Effective tax rate
25,98%
25,30%
24,93%
25,71%
Other operating expenses
789,30 m
837,40 m
522,90 m
1,04 mjd
Net income
299,70 m
205,80 m
531,60 m
644,00 m
Net profit margin
5,28%
3,55%
8,58%
8,52%
Earnings per share
-
-
-
-
Interest and investment income
-
-
149,50 m
-
Interest expense
-34,80 m
-36,30 m
-
-36,40 m
Net interest expenses
-34,80 m
-36,30 m
149,50 m
-36,40 m
Depreciation and amortization charges
199,90 m
201,80 m
202,90 m
213,40 m
EBITDA
569,70 m
547,28 m
929,82 m
1,02 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme